Close
rqi-investors-logo-ash-mint.png

formerly Realindex Investments

Leader in active quantitative equities across Australian equities, global equities, emerging markets and global small companies.

Backed by a unique blend of research, portfolio construction and risk management, focused on uncovering original insights and translating them into investment strategies that are active and systematic, aiming to generate alpha.

Discover more
Close
SI-logo-black-png.png

At Stewart Investors, we believe in putting people first. Our investment world-view is of a series of partnerships – with each other, with our clients, with the companies we invest in, the people who buy their goods and services, and with the wider society in which we all live and work.

Discover more

High conviction growth stories to watch over the next decade

High conviction growth stories to watch over the next decade

As seen in the Professional Planner

The Australian share market is fortunate to host a number of high quality, home-grown companies that have been able to transport their success in Australia to offshore locations and become global leaders. Companies with these compelling products and assets are able to ‘run their own race,’ and show potential to generate compound growth in cash flows for investors into the next decade. Here are some of the high conviction stocks we are watching, with attractive characteristics including strong franchises capable of increasing market share and the ability to grow earnings and generate superior returns on capital.

Growing sleep apnea awareness to drive market growth: ResMed

ResMed, through its continuous positive airway pressure (CPAP) masks and devices, is a global leader in the treatment of obstructive sleep apnea (OSA) with over 70% of the global market share. ResMed recently reported a robust 1Q25 profit result in October where every region and segment delivered double digit revenue growth, lifted gross margins, delivered operating leverage and improved its return on invested capital. Long term demand for ResMed’s sleep and respiratory products is generated from growing awareness and diagnosis of OSA. Awareness of OSA as a medical condition should continue to grow over time and may get a material tailwind from digital wearables such as the new Samsung Watch and the new Apple Watch that are FDA approved to diagnose sleep apnea.

The Microsoft of Global Freight Forwarding: WiseTech Global

WiseTech Global has established itself as the de facto industry standard in freight forwarding software through its renowned CargoWise product. As a result the Company has consistently delivered double digit revenue growth since it first listed on the ASX in 2016. WiseTech Global now has 14 of the 25 largest global freight forwarders using Cargowise as their core platform and has more recently guided to rising margins and accelerating revenue growth in FY25 with the launch of a number of significant new adjacent products that provide its users with valuable cost savings, lower emissions, better service and capabilities.

Cloud Adoption and AI opportunity, a long-term driver: Xero

Xero is the world pioneer for cloud-based small SME accounting software and with ~ 4.2m global subscribers is the market leader in ANZ, UK, Singapore and South Africa. Xero recently achieved its Rule of 40 target (combined revenue growth rate and profit margin equals or exceeds 40%) and delivered a refreshed FY25-27 strategy, both of which reinforced the company’s focus on balancing growth with profitability versus a growth at all costs mindset and balancing subscriber growth with price. The on-going transition from excel/desktop accounting to cloud, and the opportunity to leverage AI, provides the opportunity for Xero to accelerate their subscriber base growth over the next decade.

Pallet pooler makes strides on transformation program: Brambles

Brambles is the world’s largest pallet pooling company with over 347m pallets, crates and containers across more than 60 countries globally. Brambles has been executing its Shaping our Future transformation program that was first developed in 2021. The transformation program has helped Brambles deliver initiatives aimed at improving its asset efficiency and inventory optimisation, which has translated into a reduction in costs associated with lost assets and overall CAPEX. Further efficiency improvements should help lift Bramble’s underlying profit and free cash flow in the future.

Heading into 2025, the Australian economy is likely to be still growing steadily, as is the US whilst China slows its pace of growth. The First Sentier Investors Australian Equities Growth team is carefully analysing the profit results and business models of these companies with a focus on identifying structural winners. As one of the largest and most experienced investment teams in Australia, our insights come from very detailed analysis of the stocks in the ASX300, engaging with their management teams, clients and competitors.   

Reference to specific securities (if any) is included for the purpose of illustration only and should not be construed as a recommendation to buy or sell the same. All securities mentioned herein may or may not form part of the holdings of First Sentier Investors’ portfolios at a certain point in time, and the holdings may change over time.

Important information

This material has been prepared and issued by First Sentier Investors (Australia) IM Ltd (ABN 89 114 194 311, AFSL 289017) (FSI AIM), which forms part of First Sentier Investors, a global asset management business. First Sentier Investors is ultimately owned by Mitsubishi UFJ Financial Group, Inc (MUFG), a global financial group. A copy of the Financial Services Guide for FSI AIM is available from First Sentier Investors on its website.

This material contains general information only. It is not intended to provide you with financial product advice and does not take into account your objectives, financial situation or needs. Before making an investment decision you should consider, with a financial advisor, whether this information is appropriate in light of your investment needs, objectives and financial situation.

Any opinions expressed in this material are the opinions of the individual author at the time of publication only and are subject to change without notice. Such opinions: (i) are not a recommendation to hold, purchase or sell a particular financial product; (ii) may not include all of the information needed to make an investment decision in relation to such a financial product; and (iii) may substantially differ from other individual authors within First Sentier Investors.

We have taken reasonable care to ensure that this material is accurate, current, and complete and fit for its intended purpose and audience as at the date of publication. No assurance is given or liability accepted regarding the accuracy, validity or completeness of this material and we do not undertake to update it in future if circumstances change. No part of this material may be reproduced or transmitted in any form or by any means without the prior written consent of FSI AIM.

Any performance information has been calculated using exit prices after taking into account all ongoing fees and assuming reinvestment of distributions. No allowance has been made for taxation. Past performance is not indicative of future performance.

Copyright © First Sentier Investors, 2024

All rights reserved.